article · Biology of Sport
Integrin complexes facilitate cell communication, playing a role in ligament homeostasis. <i>ITGB2</i> rs2230528 (C/T) was implicated in anterior cruciate ligament rupture (ACL) risk in a South African cohort. Identifying biologically significant DNA signatures in the predisposition to ACL rupture risk remains important towards understanding mechanisms of ACL ruptures. <i>ITGB2</i> is essential for the activation of important biological pathways regulated by structural components such as collagens and biomechanical components such as vasculo-endothelial growth factors. This study tested the association of (i) <i>ITGB2</i> rs2230528 and (ii) allele-allele combinations of <i>ITGB2's</i> network partners (<i>COL5A1</i> rs12722 C/T, <i>VEGFA</i> rs699947 C/A and <i>VEGFA</i> rs2010963 G/C) with ACL rupture risk. The genetic study was conducted in a combined cohort [n=1279: uninjured controls (CON), n=548; ACL ruptures (ACL), n=731; subgroup with non-contact mechanism of ACL ruptures (NON, n=425)] recruited from Australia, Poland, Sweden and South Africa. The combined cohort, rs2230528 TT (best fit model) was significantly over-represented in the ACL (p=8.00 × 10<sup>-8</sup>; OR:3.21; 95% CI:2.10-4.89, AIC=1549) and NON (p=1.59 × 10<sup>-6</sup>; OR:3.11; 95% CI:1.97-4.91, AIC=1191) groups compared to CON. <i>ITGB2</i> rs2230528-COL5A1 rs12722-<i>VEGFA</i> rs699947-<i>VEGFA</i> rs2010963, the C-C-A-G and C-T-C-G combinations were significantly associated with reduced ACL risk. This study provided additional evidence highlighting <i>ITGB2</i> as potentially being associated with ACL ruptures even though the gene-gene combinations had a small effect size. Integrins containing the b2 subunit together with its key extracellular matrix components (type V collagen and VEGFA) are potential therapeutic targets for ACL ruptures and potentially other connective tissue-related conditions.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.5114/biolsport.2026.152346
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.